Rocbrutinib
洛布替尼
Report date: 2026/05/25 20:02:40
NME
Base Information
Drug NameRocbrutinib
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[14]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesNewave Pharmaceutical Inc
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesNewave Pharmaceutical IncHansoh Pharmaceutical Group Company LtdJiangsu Hansoh Pharmaceutical Group Co Ltd +[5]
Inactive CompaniesN/A
Active Indications +[13]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A